Key result
Dual-chamber ICD implantation via persistent left SVC maintains stable pacing parameters through ~6 months.
Why the study?
Persistent left superior vena cava is a congenital anomaly in 0.3-0.5% of patients whose multiple and complex anatomical variations can make transvenous cardioverter defibrillator lead placement challenging.
Case Report (n=1)
No
Demonstrates the technical feasibility of utilizing both a persistent left superior vena cava/coronary sinus and a narrow bridging innominate vein to achieve stable dual-chamber ICD lead placement without inter-lead interference.
Answers are grounded in this paper and cite their sources.
Supports feasibility of dual-chamber ICD via persistent left SVC; hypothesis-generating, prospective validation required before wider use.
Persistence of the left superior vena cava (PLSVC) is a congenital anomaly reported in 0.3-0.5% of patients. Due to the multiple and complex anatomical variations, transvenous lead placement can become challenging. We report the case of a 47-year-old patient diagnosed with non-ischemic dilated cardiomyopathy with reduced left ventricular ejection fraction (LVEF-27%), who was referred to our clinic for implantation of a dual-chamber cardioverter defibrillator for primary prevention of sudden cardiac death. During the procedure we encountered an abnormal guidewire trajectory and after venographic examination we established the diagnosis of persistent left superior vena cava. After difficult implantation of a 7F defibrillation lead through the coronary sinus, we managed to place the atrial lead through a narrow brachiocephalic vein into the right atrial appendage. In this paper, we aim to illustrate the medical and technical implications of implanting a cardioverter defibrillator in patients with PLSVC, highlighting the benefit of identifying and utilizing both the innominate vein, and the left superior vena cava and coronary sinus for placement of multiple leads, which would otherwise have been impossible.
No takes yet. Share an insight, caveat, or question.
Haba et al. (2020) conducted a case report in Non-ischemic dilated cardiomyopathy with reduced left ventricular ejection fraction (LVEF 27%) and persistent left superior vena cava (PLSVC type IIIa) (n=1). Dual-chamber implantable cardioverter-defibrillator (ICD) implantation using both the left superior vena cava/coronary sinus (7F RV lead) and the bridging innominate vein/right superior vena cava (atrial lead) was evaluated on Device and lead stability, pacing/sensing parameters, and procedural complications at 6 months. Dual-chamber ICD implantation via the persistent left superior vena cava and bridging innominate vein achieved stable lead parameters over 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: